🇫🇷 Induction- PF-06480605 150 mg SC Q4W in France

Induction- PF-06480605 150 mg SC Q4W (induction-pf-06480605-150-mg-sc-q4w) regulatory status in France.

Marketing authorisation

ANSM

  • Status: approved

Induction- PF-06480605 150 mg SC Q4W in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in France

Frequently asked questions

Is Induction- PF-06480605 150 mg SC Q4W approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Induction- PF-06480605 150 mg SC Q4W in France?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.